Rosenthal MA - Search Results

1

Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin.

Rosenthal MA, Kavar B, Hill JS, Morgan DJ, Nation RL, Stylli SS, Basser RL, Uren S, Geldard H, Green MD, Kahl SB, Kaye AH. Rosenthal MA, et al. J Clin Oncol. 2001 Jan 15;19(2):519-24. doi: 10.1200/JCO.2001.19.2.519. J Clin Oncol. 2001. PMID: 11208846 Clinical Trial.

2

Recent advances in parathyroid tumors and paragangliomas.

Rosenthal MA, Green MD. Rosenthal MA, et al. Curr Opin Oncol. 1992 Feb;4(1):99-104. doi: 10.1097/00001622-199202000-00013. Curr Opin Oncol. 1992. PMID: 1317216 Review.

3

Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancy.

Basser RL, Sobol MM, Duggan G, Cebon J, Rosenthal MA, Mihaly G, Green MD. Basser RL, et al. Among authors: rosenthal ma. J Clin Oncol. 1994 Aug;12(8):1659-66. doi: 10.1200/JCO.1994.12.8.1659. J Clin Oncol. 1994. PMID: 8040678 Clinical Trial.

4

Primary cerebral lymphoma: an argument for the use of adjunctive systemic chemotherapy.

Rosenthal MA, Sheridan WP, Green MD, Liew K, Fox RM. Rosenthal MA, et al. Aust N Z J Surg. 1993 Jan;63(1):30-2. doi: 10.1111/j.1445-2197.1993.tb00029.x. Aust N Z J Surg. 1993. PMID: 8466457

5

Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: phase II studies by the Eastern Cooperative Oncology Group.

Rosenthal MA, Green M, Wiernik P, Borden EC, Marsh JC, Haller DG. Rosenthal MA, et al. Am J Clin Oncol. 1998 Oct;21(5):509-12. doi: 10.1097/00000421-199810000-00019. Am J Clin Oncol. 1998. PMID: 9781611 Clinical Trial.

6

Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme.

Rosenthal MA, Gruber ML, Glass J, Nirenberg A, Finlay J, Hochster H, Muggia FM. Rosenthal MA, et al. J Neurooncol. 2000 Mar;47(1):59-63. doi: 10.1023/a:1006426215005. J Neurooncol. 2000. PMID: 10930101 Clinical Trial.

7

An Australian experience with temozolomide for the treatment of recurrent high grade gliomas.

Harris MT, Rosenthal MA, Ashley DL, Cher L. Harris MT, et al. Among authors: rosenthal ma. J Clin Neurosci. 2001 Jul;8(4):325-7. doi: 10.1054/jocn.2000.0809. J Clin Neurosci. 2001. PMID: 11437571

8

Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia.

Rosenthal MA, Rischin D, McArthur G, Ribbons K, Chong B, Fareed J, Toner G, Green MD, Basser RL. Rosenthal MA, et al. Ann Oncol. 2002 May;13(5):770-6. doi: 10.1093/annonc/mdf117. Ann Oncol. 2002. PMID: 12075747 Free article. Clinical Trial.

9

Promising survival in patients with high-grade gliomas following therapy with a novel boronated porphyrin.

Rosenthal MA, Kavar B, Uren S, Kaye AH. Rosenthal MA, et al. J Clin Neurosci. 2003 Jul;10(4):425-7. doi: 10.1016/s0967-5868(03)00062-6. J Clin Neurosci. 2003. PMID: 12852879 Clinical Trial.

10

A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer.

Jefford M, Michael M, Rosenthal MA, Davis ID, Green M, McClure B, Smith J, Waite B, Zalcberg J. Jefford M, et al. Among authors: rosenthal ma. Invest New Drugs. 2004 Apr;22(2):185-92. doi: 10.1023/B:DRUG.0000011796.20332.a9. Invest New Drugs. 2004. PMID: 14739668 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters